ClinConnect ClinConnect Logo
Search / Trial NCT06118606

Pilot Study of a Multidisciplinary Intervention in ICU Survivors At Risk for Psychological or Physical Morbidity

Launched by REGION STOCKHOLM · Nov 1, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Post Intensive Care Syndrome Pilot Study Early Follow Up Intervention

ClinConnect Summary

This clinical trial is looking at a new way to help patients who have spent time in the Intensive Care Unit (ICU) and may be at risk for emotional or physical issues afterward. The researchers want to see if an early, team-based approach can make a difference for these patients, helping them manage problems like anxiety, depression, or physical disabilities that can occur after their ICU stay.

To be eligible for this study, participants should be between the ages of 65 and 74 and have been in the ICU for at least 12 hours. They need to show signs that they might have problems after their ICU experience, based on specific assessments used in the study. However, individuals with serious cognitive issues, major brain or spinal injuries, or those who cannot communicate in Swedish are not eligible. If you choose to participate, you can expect to work with a team of healthcare professionals focused on your recovery and well-being during your hospital stay.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • - Patients admitted ≥12 hours to the ICU with an increased risk for physical or psychological sequelae (assessed with the PROGRESS-ICU/PREPICS instruments)
  • Exclusion Criteria:
  • Dementia or other major cognitive problems
  • Structural brain or spinal cord injury
  • Multiple limitations of medical treatment
  • Insufficient language skills (Swedish)

About Region Stockholm

Region Stockholm is a leading healthcare authority committed to advancing medical research and improving patient care through innovative clinical trials. As a sponsor, Region Stockholm collaborates with hospitals, research institutions, and industry partners to facilitate the development of new therapies and treatment protocols. With a focus on quality, safety, and ethical standards, the organization aims to enhance health outcomes for the diverse population of Stockholm and beyond, leveraging cutting-edge research to translate scientific discoveries into effective healthcare solutions.

Locations

Stockholm, , Sweden

Stockholm, , Sweden

Patients applied

0 patients applied

Trial Officials

Anna Milton

Principal Investigator

Karolinska Institutet/Karolinska University Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported